Call for Abstract

10th International Conference on Cancer & Tumor Immunology, will be organized around the theme ““Explore the Possibilities in the Field of Cancer and Tumor””

Cancer Immunology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Immunology 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer immunology will outline the basic biology of immune responses with the goal of developing new immune therapy approaches and improving existing ones. Basic research to investigate, at the cellular and molecular levels, the mechanisms that regulate the immune system, yielding knowledge that will further our efforts to harness the power of the immune system to treat cancer.

  • Track 1-1Brain Cancer
  • Track 1-2Bone Cancer
  • Track 1-3Esophageal Cancer
  • Track 1-4Vaginal Cancer
  • Track 1-5Penile Cancer
  • Track 1-6Adrenal Cancer
  • Track 1-7Gall Bladder Cancer
  • Track 1-8Tubal Cancer
  • Track 1-9Gastric Cancer
  • Track 1-10Tonsil Cancer
  • Track 1-11Testicular Cancer
  • Track 1-12Colorectal cancer
  • Track 1-13Thyroid Cancer
  • Track 1-14Breast Cancer
  • Track 1-15Skin Cancer
  • Track 1-16Cervical Cancer
  • Track 1-17Liver Cancer
  • Track 1-18Pancreatic Cancer
  • Track 1-19Prostate Cancer
  • Track 1-20Uterine Cancer
  • Track 1-21Esophageal Cancer
  • Track 1-22Spinal Cancer
  • Track 1-23Renal Cancer
  • Track 1-24Bladder Cancer

Tumor Immunology determining the function and behavior of innate and adaptive immune cells in health and disease, including the interactions with their microenvironment. Understanding the basic principles underlying immune cell development, activation, regulation, differentiation and death as well as the molecular mechanisms underlying diversity and plasticity of the immune system is a prerequisite for the design of targeted manipulation strategies to protect from cancer, autoimmunity and infection and to foster and devise the development of novel therapeutic approaches. To address their research questions the individual groups develop and use sophisticated experimental model systems and technologies such as genetic barcoding, structural biology and high-throughput single cell analysis platforms.

  • Track 2-1Tumor and its Classification
  • Track 2-2Immune modulation of Tumors

Covers all areas of immunology including cellular and molecular immunology, immunochemistry, immunogenetics, imaging, mathematical modelling, allergy, transplantation immunology, cancer immunology, clinical immunology and immunological therapies, physiological functioning of the immune system in states of both health and disease, malfunctions of the immune system in immunological disorders and therapies (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection), the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo are of prime interest.

  • Track 3-1Tumor Antigens
  • Track 3-2Immune systems Stimulants
  • Track 3-3Newer Monoclonal Antibodies
  • Track 3-4Targeting Immunotherapy Cancer Treatment
  • Track 3-5Sublingual immunotherapy

Prolonged inflammation can damage your body’s healthy cells and tissue, and weaken your immune system, The link between inflammation and cancers, cancers tended to occur at sites of chronic inflammation. Lately, it turned out that acute inflammation contributed to the regression of cancer. inflammation and innate immunity are important targets in patients with cancer

  • Track 4-1Acute Inflammation
  • Track 4-2Chronic Inflammation

People with HIV/AIDS are at high risk for developing certain cancers, such as Kaposi's sarcoma, non-Hodgkin lymphoma, and cervical cancer. For people with HIV, these three cancers are often called "AIDS-defining conditions. Most types of cancer begin when normal cells begin to change and grow uncontrollably, forming a mass called a tumor. A tumor can be benign (noncancerous) or malignant (cancerous, meaning it can spread to other parts of the body).

  • Track 5-1HIV vaccines
  • Track 5-2New Theraputic Approaches

Cancers are not just masses of malignant cells but complex ‘rogue’ organs, to which many other cells are recruited and can be corrupted by the transformed cells. Interactions between malignant and non-transformed cells create the tumor microenvironment. Changes of the tumor microenvironment have been closely correlated to cancer-mediated inflammation. 

  • Track 6-1Targeting myloma with Microenvinorment
  • Track 6-2Characterstics of Micro envinorment

A cancer vaccine is a vaccine that treats with existing cancer or prevents development of a cancer. Cancer vaccines are also   known as biological response modifiers. A biological response modifier helps by stimulating or restoring the immune system’s ability to fight infections and disease. The most commonly used side effect of cancer vaccines is inflammation at the site of injection, including redness, pain, swelling, warming of the skin, itchiness, and occasionally a rash. Mainly these vaccines include cell therapy and gene therapy.

  • Track 7-1Cell Therapy
  • Track 7-2Gene Therapy
  • Track 7-3Metabolomic cancer therapy
  • Track 7-4Hormone therapies
  • Track 7-5Chemotherapy

Cancer prognosis gives us information about the percentage of people who survive a certain type of cancer for specific amount of time. Some of the factors that affect  prognosis like  type of cancer, its location in the body,  stage, size of the cancer,  cancer’s grade and age of the patients etc… The time of period varies; it may be 1 year, 2 years, 5 years, and etc... Cancer-specific survival is also called as Disease-specific survival. There are different ways to measure and report survival and statistics of cancer. This cancer prognosis that mainly include liver cancer prognosis, metastatic prognosis and brain cancer prognosis

  • Track 8-1 Liver cancer Prognosis
  • Track 8-2Metastaic Prognosis
  • Track 8-3Brain Cancer Prognosis

Cancer cell biology can be defined as a disease of the genes. This is the small part of DNA and master molecule of the cell. The main two characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate and spread to distant sites. If the spread is not controlled, cancer can result in death. Bone marrow stromal stem cells also called mesenchyme stem cells or skeletal stem cells and these can generate bone, cartilage, and fat cells. The cancer pathology is a medical document that written by a pathologist. A pathologist is a doctor who specializes in interpreting laboratory tests and evaluating cells, tissues, and organs to diagnose disease.

  • Track 9-1Cancer Stem Cells
  • Track 9-2Cancer Pathology
  • Track 9-3Clinical oncology
  • Track 9-4Surgical Oncology
  • Track 10-1Molecular & cellular oncology
  • Track 10-2Immuno-Oncology
  • Track 10-3cellular pathology
  • Track 10-4Islet Cell Tumor
  • Track 10-5Genomic tumor assessment
  • Track 10-6Tumor molecular profiling
  • Track 11-1Distribution of economic impact
  • Track 11-2Estimation of direct and indirect cost of cancer
  • Track 11-3Socio economic disparities in cancer burden
  • Track 11-4Anticancer drugs in global market: economy and their cost effectiveness
  • Track 12-1Cancer Immunology Research
  • Track 12-2Clinical Cancer Research
  • Track 12-3Molecular Cancer Research
  • Track 12-4Molecular Cancer Therapeutics
  • Track 12-5Cancer Prevention Research
  • Track 12-6Radiation oncology research
  • Track 13-1Gastrointestinal
  • Track 13-2Genitourinary
  • Track 13-3 Melanoma
  • Track 14-1Molecular Cancer Therapeutics
  • Track 14-2Metabolomics in Novel Biomarker Discovery